To generate an immunocompetent mouse model of huHER2-amplified cancer with improved tumour take rates and less spontaneous tumour regression, we engineered a truncated variant of HER2 (HER2T) from which the outermost immunogenic domains and intracellular kinase domain were removed (21) (Figure 2A). The gene discussed is ERBB2; the disease is cancer.